Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma

Background: Esophageal adenocarcinoma (EAC) remains a leading cause of cancer-related deaths worldwide and demonstrates a predominant rising incidence in Western countries. Recently, immunotherapy has dramatically changed the landscape of treatment for many advanced cancers, with the benefit in EAC...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Genet
Auteurs principaux: Liu, Zaoqu, Liu, Long, Jiao, Dechao, Guo, Chunguang, Wang, Libo, Li, Zhaonan, Sun, Zhenqiang, Zhao, Yanan, Han, Xinwei
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2021
Sujets:
Genetics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8166246/
https://ncbi.nlm.nih.gov/pubmed/34079583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2021.669694
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires